J Periodontol:牙周骨缺损再生治疗后的长期稳定性:回顾性病例系列

2017-06-26 MedSci MedSci原创

本研究旨在评估牙周骨缺损(IBD)后再生治疗组织附着的长期稳定性。

本研究旨在评估牙周骨缺损(IBD)后再生治疗组织附着的长期稳定性。

实验对2004年至2010年期间至少接受一次IBD再生治疗的所有患者进行回顾性病例系列筛查。如果患者在术前和手术后12个月完成检查(菌班/牙龈指数,探诊深度[PD],临床垂直附着水平[CAL-V])),术后60±12个月需要进行复诊检查。复查包括检测白细胞介素(IL)-1多态性和牙周支持治疗(SPT)访视次数。实验共纳入41例患者(男24例,女17例,年龄中位数:62.0岁,下/上四分位数:49.8 / 68.3岁; 6例吸烟者,9例IL-1阳性),每个患者都有一处IBD。

结果:再生治疗1年(中位数:-3mm,下/上四分位数:-1.5 / -4mm; P <0.001)和5年(中位数:-3mm,下/上四分位数-1.9 /4.5 mm; P <0.001)均有显着地附着增加。实验未能检测出手术后1~5年的CAL-V中位数变化(中位数:0 mm;下/上四分位数:-1 / 1.5 mm; P = 0.84)。多元回归分析表明,术后1~5年SPT访视次数与CAL-V增加相关。 5年复查时,IL-1多态性和PD> 6 mm位点的百分比与手术后1~5年的CAL-V丧失相关。

结论:IBD通过再生治疗实现的CAL-V可能在5年内保持稳定。频繁的SPT有助于稳定性, IL-1多态性和广泛再感染与稳定性差有关。

原始出处:

Katrin Nickles, Bettina Dannewitz, Kerstin Gallenbach, et al. Long-Term Stability After Regenerative Treatment of Infrabony Defects: A Retrospective Case Series. Journal of Periodontology. 2017 June. doi: 10.1902/jop.2017.160704
版权声明:本文系梅斯MedSci原创编译整理,未经本网站授权不得转载和使用。如需获取授权,请点击

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1900456, encodeId=839f190045629, content=<a href='/topic/show?id=0983e529745' target=_blank style='color:#2F92EE;'>#稳定性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75297, encryptionId=0983e529745, topicName=稳定性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sun Jan 28 13:27:00 CST 2018, time=2018-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726516, encodeId=390e1e26516b5, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 05 02:27:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419233, encodeId=24101419233e2, content=<a href='/topic/show?id=2e2e10182602' target=_blank style='color:#2F92EE;'>#骨缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101826, encryptionId=2e2e10182602, topicName=骨缺损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51173492599, createdName=lfcmxl, createdTime=Wed Jun 28 13:27:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1450544, encodeId=16ff1450544b3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=liuyong2982, createdTime=Wed Jun 28 13:27:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1900456, encodeId=839f190045629, content=<a href='/topic/show?id=0983e529745' target=_blank style='color:#2F92EE;'>#稳定性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75297, encryptionId=0983e529745, topicName=稳定性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sun Jan 28 13:27:00 CST 2018, time=2018-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726516, encodeId=390e1e26516b5, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 05 02:27:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419233, encodeId=24101419233e2, content=<a href='/topic/show?id=2e2e10182602' target=_blank style='color:#2F92EE;'>#骨缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101826, encryptionId=2e2e10182602, topicName=骨缺损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51173492599, createdName=lfcmxl, createdTime=Wed Jun 28 13:27:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1450544, encodeId=16ff1450544b3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=liuyong2982, createdTime=Wed Jun 28 13:27:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
    2018-02-05 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1900456, encodeId=839f190045629, content=<a href='/topic/show?id=0983e529745' target=_blank style='color:#2F92EE;'>#稳定性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75297, encryptionId=0983e529745, topicName=稳定性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sun Jan 28 13:27:00 CST 2018, time=2018-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726516, encodeId=390e1e26516b5, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 05 02:27:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419233, encodeId=24101419233e2, content=<a href='/topic/show?id=2e2e10182602' target=_blank style='color:#2F92EE;'>#骨缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101826, encryptionId=2e2e10182602, topicName=骨缺损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51173492599, createdName=lfcmxl, createdTime=Wed Jun 28 13:27:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1450544, encodeId=16ff1450544b3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=liuyong2982, createdTime=Wed Jun 28 13:27:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
    2017-06-28 lfcmxl
  4. [GetPortalCommentsPageByObjectIdResponse(id=1900456, encodeId=839f190045629, content=<a href='/topic/show?id=0983e529745' target=_blank style='color:#2F92EE;'>#稳定性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75297, encryptionId=0983e529745, topicName=稳定性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sun Jan 28 13:27:00 CST 2018, time=2018-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726516, encodeId=390e1e26516b5, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 05 02:27:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419233, encodeId=24101419233e2, content=<a href='/topic/show?id=2e2e10182602' target=_blank style='color:#2F92EE;'>#骨缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101826, encryptionId=2e2e10182602, topicName=骨缺损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51173492599, createdName=lfcmxl, createdTime=Wed Jun 28 13:27:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1450544, encodeId=16ff1450544b3, content=<a href='/topic/show?id=f0476e49582' target=_blank style='color:#2F92EE;'>#牙周#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67495, encryptionId=f0476e49582, topicName=牙周)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=liuyong2982, createdTime=Wed Jun 28 13:27:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]

相关资讯

J Clin Periodontol:多聚(ADP-核糖)聚合酶的活化在糖尿病牙周炎发病机制中的作用

背景: 糖尿病者进行性牙周炎的病因尚未阐明。之前实验证明患有牙周炎的糖尿病大鼠亚硝化压力增加。亚硝化压力介导多聚(ADP-核糖)聚合酶(PARP)的激活。文章证明了PARP激活参与糖尿病牙周炎,并详细介绍了PARP抑制剂的治疗作用。

J Clin Periodontol:牙周炎患者可溶性CD163水平升高

可溶性CD163(sCD163)已经被认为是炎症性疾病中的新生物标志物。该实验研究了慢性牙周炎患者中全身和局部CD163水平。

J Clin Periodontol:牙周炎通过氧化应激和脂质过氧化反应改变肾结构

近日,有研究调查实验性牙周炎是否导致肾脏组织变化和肾脏氧化应激失衡。

J Clin Periodontol:针对类风湿性关节炎和牙周炎患者中瓜氨酸化组蛋白H3的自身抗体

近日,有实验研究检测炎症牙周组织中瓜氨酸化组蛋白的存在并确定类风湿性关节炎(RA)和牙周炎(PD)患者血清中抗瓜氨酸化的组蛋白自身抗体的存在。

Clin Oral Investig:干燥剂在治疗慢性牙周炎中的效果研究:一项临床随机对照试验

化学治疗药物一直以来作为慢性牙周炎(CP)的辅助治疗被广泛应用。这项研究是为了检测洁治加根面平整(SRP)辅以干燥剂疗法对治疗CP效果的影响,并与单独使用SRP做比较。

J Clin Periodontol:牙周治疗附加系统性抗菌治疗对代谢综合征指标的影响

这篇研究的目的是为了评估牙周基础治疗(BPT)附加抗菌治疗(AM)对代谢综合征(MetS)指标(腰围、收缩/舒张血压、高密度脂蛋白、甘油三酯和葡萄糖)的影响。